×

Antisense modulation of caspase 9 expression

  • US 6,492,170 B1
  • Filed: 09/11/2000
  • Issued: 12/10/2002
  • Est. Priority Date: 09/11/2000
  • Status: Expired due to Fees
First Claim
Patent Images

1. A compound up to 50 nucleobases in length comprising at least an 8-nucleobase portion of SEQ ID NO:

  • 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 60, 61, 62, 63, 64, 65, 66, 67, 68, 70, 71, 72, 73, 74, 75, 76, 77, 78, 80, 81, 83, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 100, 101, 102, 103, 105, 106, 108, 109, 110, 111, 112, 113, 114, 116, 117, 118, 122, 124, 125, 126, 127, 128, 129, 131, 132, 133, 134, 135, 136, 137, 139, 140, 141, 143, 144, 145, 146, 147, 150, 152, 154, 155, 156, 157, 158, 159, 161, 162, 163, 164, 165, 166, 168, 169, 170, 171, 172, 173 or 174 which inhibits the expression of caspase 9.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×